Category Archives: Cell Biology

New study: How is growing R&D investments in Drug Discovery and Development Driving Synthetic Biology Market? – WhaTech Technology and Markets News

Asian synthetic biology market is expected to witness fastest growth, with a CAGR of 39.8% during the forecast period.

The need for advanced and innovative drug discovery and development has increased considerably as the prevalence of various diseases, such as neurological disorders, immunological disorders, infectious diseases, and cancer is rising. Due to this, several biopharmaceutical and pharmaceutical companies are becoming more inclined toward the development of new and more effective biopharmaceutical drugs.

This in turn, has been made possible because of the growing research and development investments in drug discovery and development. Since synthetic biology provides innovative solutions for drug discovery, its demand is surging as well.

Using synthetic biology, living organisms are genetically developed for required functions in research laboratories. The field derives input from molecular and cell biology, biochemistry, bioinformatics, mathematics, and evolutionary systematics.

Synthetic biology elucidates disease mechanisms and target identification, along with providing avenues to design and discover novel biopharmaceuticals and small chemotherapeutic molecules.

Download sample copy of this report at@bit.ly/3a0D2Bi

According to a research conducted by the P&S Intelligence, the global synthetic biology market size is expected to generate a revenue of $23.8 billion and advance at a CAGR of 35.4% in the near future.

Among several reasons for the growth of this market is the increasing geriatric population.

According to the United Nations Department of Economic and Social Affairs, the population of people aged 60 years and above is rising at a high rate; the number rose from 9.2% in 1990 to 11.7% in 2013 and is further predicted to reach 21.1% by 2050. People aged 60 years and above are more prone to illness because of low immunity and metabolic rate, due to which diseases such as cancer and immunological diseases affect elderly people more severely.

The treatment of such diseases requires more effective biotherapeutics and synthetic biology helps achieve the same by enabling designing of novel strategies for the treatment as well as production of cheap drugs.

Pre-Access Inquiry at@bit.ly/3c8FnvJ

Several applications of synthetic biology are chemical, agriculture, pharmaceutical & diagnostic, energy, and research & development. The largest demand for synthetic biology was created by the pharmaceutical & diagnostic application during 20112014 and the situation is going to be the same in the coming years as well.

The combination of medical science and synthetic biology allows swift discovery of therapeutics and target-specific antibodies, along with peptide screening with degenerate gene libraries. Furthermore, synthetic biology involves the development of several diagnostic technologies for diseases, such as metabolic disorders, immunological disorders, and others.

This email address is being protected from spambots. You need JavaScript enabled to view it.

Read the original:
New study: How is growing R&D investments in Drug Discovery and Development Driving Synthetic Biology Market? - WhaTech Technology and Markets News

Hunting Hibernating Breast Cancer Cells in the Lung – Technology Networks

Healthy lung cells support the survival of breast cancer cells, allowing them to hibernate in the lung before forming secondary tumours, according to new research from the Crick. The findings could help the development of new treatments that interfere with this behaviour, reducing the number of secondary cancers.

The study, published inNature Cell Biology, used a mouse model to show that, after cancer cells from a breast tumour arrive in the lungs, a signal sent out from the lung cells causes cancer cells to change shape and grow protrusions that latch onto the lung tissue. The lung cells then protect them within the lung tissue.

By using a treatment that interferes with the growth of these protrusions on the breast cancer cells, the researchers found that mice who received the treatment grew fewer secondary tumours than the control mice.

The researchers then analysed the genes that are turned on in the hibernating cells. This enabled them to find a key gene,sFRP2, that regulates the formation of cell protrusions and the survival of breast cancer cells in the lung.

Cancer can survive, hibernating in different parts of the body, for many years. By showing how the microenvironment around the cancer cell can support its survival, in our case how the lung cells help the breast cancer cells, opens the door to potential new treatments which target this relationship, saysErik Sahai, co-lead author and group leader of the CricksTumour Cell Biology Laboratory.

The cancer cells were tested over the course of up to four weeks, during which they remained inactive. In comparison, other cell types continued to remain active, showing that the hibernation of these cells is due to a special relationship they have with the lung environment around them.

Featured teams:

The mechanism behind how cancer cells survive in tissues they have travelled to is not yet well understood. But with many cancers spreading around the body and consequently many patients suffering from relapses, a deeper understanding of the process is vital and something well continue to explore, says Marco Montagner, co-lead author and former postdoc in the CricksTumour Cell Biology Laboratory, who is now based at theUniversity of Padua.

Around 55,000 people in the UK are diagnosed with breast cancer each year. This cancer can spread through the blood or lymphatic system to another part of the body, commonly the lungs, liver, brain or bones. Where breast cancer spreads to the lungs, there can be a long time between the cells arriving in the lungs and the formation of a secondary tumour. This gap is one factor that explains why people may relapse a long time after the initial disease.

The researchers are continuing to explore the relationship between cancer and non-cancerous cells in a secondary location in the body. At the Crick, researchers are now studying what happens when cells from colorectal cancer and melanomas form secondary tumours in the liver. While at the University of Padua, studies are ongoing into the genes which are over-expressed in hibernating breast cancer cells.

Reference: Montagner, et al. (2020) Crosstalk with lung epithelial cells regulates Sfrp2-mediated latency in breast cancer dissemination.Nature Cell Biology.DOI:https://doi.org/10.1038/s41556-020-0474-3

This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.

More:
Hunting Hibernating Breast Cancer Cells in the Lung - Technology Networks

New imaging tool to track cellular events that may initiate obesity-related conditions – News-Medical.net

A collaborative team of researchers at Utah State University and the University of Central Florida developed a tool to track cellular events that may lead to obesity-related conditions in people.

The research findings were published Feb. 3 in the Proceedings of the National Academy of Sciences.

The team, led by Anhong Zhou, a professor in USU's Department of Biological Engineering, developed a sensing optical imaging nanoprobe that uses scattered light to provide a structural fingerprint for molecules. The probes can be used to more easily identify and illustrate cell surface receptors that can either prompt or stop cellular responses to certain external stimuli. The probes make it possible to monitor multiple surface receptors on an individual cell and provide researchers an unprecedented view of cellular surface activity. Zhou and his team, including the biological engineering PhD student Wei Zhang, applied these novel nanoprobes to successfully detect the cell receptors that recognize fatty acids at the single living cell level.

The technique represents a major step in developing improved understanding of certain cellular events and could have widespread impact on the study of fat intake and the development of obesity. The new method could also be used as a simple screening technique for testing external stimuli that trigger the surface cell receptors and lead to the linking of fatty acids. This would make for an efficient test to ensure that new drugs accurately prompt the correct cellular activities that lead to obesity and other obesity-related conditions. Zhou and his team's work is increasingly relevant as the prevalence of obesity impacts public health in the United States.

Zhou says the research represents an exciting collaboration between researchers and aligns well with his belief that biological engineering is an important frontier in the scientific community.

This is an excellent example that fulfills our long-term goal of applying engineering tools to solve biology-driven problems. In the past several years, we have been thrilled to develop new cell-based assay technologies that potentially benefit human health problems like obesity. We are currently extending this technology for developing a new method for early cancer diagnosis."

Anhong Zhou, professor in USU's Department of Biological Engineering

This work was primarily supported by the National Science Foundation.

Source:

Journal reference:

Zhang, W., et al. (2020) Spatiotemporal dynamic monitoring of fatty acidreceptor interaction on single living cells by multiplexed Raman imaging. PNAS. doi.org/10.1073/pnas.1916238117.

Posted in: Cell Biology

Tags: Assay, Cancer, Cancer Diagnosis, Cell, Drugs, Fatty Acids, Imaging, Obesity, Optical Imaging, Public Health, Research

Link:
New imaging tool to track cellular events that may initiate obesity-related conditions - News-Medical.net

Here’s the Pro-Bernie Climate Scientist Op-Ed the Washington Post Wouldn’t Run – Gizmodo

On Sunday, the Washington Post published an opinion piece by Fred Hiatt, the opinion pages editor, entitled How Donald Trump and Bernie Sanders Both Reject the Reality of Climate Change. This false equivalence is, to put it bluntly, absolutely one of the most idiotic things I have ever seen.

Hiatts piece inexplicably attacks the climate plan Senator Bernie Sanders would implement as president (heres our analysis). While there are valid things to quibble with, Hiatt does a lot of hand waving bUt HoW wOuLd We PaY fOr It stuff and hand wringing over the idea that fossil fuel companies and the executives who run them should be prosecuted. He then turns to extensively quoting and paraphrase Patrick Pouyann, the chairman and CEO of Total, a [checks notes] large Paris-based oil giant currently being sued in France.

The whole post reads like an advertorial for Total (sample quote: Pouyann himself did not seem particularly hateful; on the contrary) and a carbon tax plan supported by the Climate Leadership Council, a group supported by Big Oil, including Total.

Both sidesing Trump and Sanders and credulously burbling out Big Oil talking points would be bad enough. But a group of scientists with the Sunrise Movement tweeted that the Post opinion section had previously rejected an op-ed they submitted defending Sanders climate plan and how seriously it takes the science. It was written in response to Joe Biden dismissing Sanders plan late last month, much as Hiatt did in his Sunday piece.

Earther reached out to Sunrise Scientists, and they shared their piece with us. Emails reviewed by Earther also confirm that a Washington Post editor explicitly declined to run the op-ed. Read the scientists article in full below, along with a list of authors who helped draft it.

Note: The letter is signed by the individual scientists and does not reflect the view of the institutions with which they are affiliated.

Joe Biden says Bernie Sanders Green New Deal is impossible.

We refuse that narrative. We are scientists here to refute Bidens claim that not a single, solitary scientist thinks that [Sanders Green New Deal would] work. Not only do we believe that it is possible for the U.S. to decarbonize electricity and transportation by 2030, we know that such a goal is imperative.

The Intergovernmental Panel on Climate Change, the worlds primary scientific authority on climate change, has been describing the immense harm that climate change will bring to the world and its peoples for decades. In 2018, it issued a report focused on the likely impacts of allowing global warming of 1.5. degrees Celsius (2.7 degrees Fahrenheit) above pre-industrial warming, concluding in its famously measured phrasing that the global impacts of such warming are going to be bad. One example: Any increase in global warming is projected to affect human health, with primarily negative consequences (high confidence). Nonetheless, limiting warming to 1.5 degrees Celsius can protect people and our planet from the most extreme anticipated consequences of climate change.

The planet has already warmed 0.8-1.2 degrees Celsius (1.4-2.2 degrees Fahrenheit), with an estimated future warming trajectory of 0.1-0.3 degrees Celsius (0.2-0.6 degrees Fahrenheit) per decade. Global mean sea level has already risen 89 inches (2124 centimeters) since 1880 and is expected to rise by another 10-30 inches (26 to 77 centimeters) by 2100 under a 1.5 degrees constraint, or more if we go past that. We are running out of time.

We know we must act. Constraining climate change in a way that is most protective of our planet, our families, and our homes requires cutting greenhouse gas emissions rapidly and permanently. We believe that Bernie Sanders Green New Deal proposal lays out a course of action that is matched to the scale of the challenge. It is possible. But we must commit wholeheartedly.

Sanders Green New Deal is informed by science, linking its targets and timelines to what the science tells us is critical for staving off the most devastating impacts of climate change. Just as importantly, it understands the challenge for what it is: A need to transform our economy to support a more sustainable, healthier future.

Accordingly, it addresses decarbonization systemically, focusing on where money needs to be spent, where social programs need to be implemented, and where people need support to do great things. The plan funds new, clean energy, leveraging successful New Deal models of public financing and control of power generation, and fully funds a just, five-year transition for workers in the fossil fuel industry.

The plan recognizes climate change as an emergency. It would make the U.S. a global leader on climate action, while ensuring funding for a just transition and industrialization of the developing world. And perhaps most importantly, the plan reflects that it is the American people who will make this happen. Thats why Sanders Green New Deal focuses on jobs, justice, and public ownership of the energy systems that we create and will be bolstered by other policy commitments like Medicare for All, student loan forgiveness, union empowerment, and other programs that recognize the power and dignity of all.

We know that it is possible to rise to the challenge of the climate crisis. And we know that Sanders Green New Deal is a commitment to people that recognizes that only together can we make this deeply ambitious and critically necessary plan work. As President John F. Kennedy said to Congress at the advent of the Space Race: I believe we possess all the resources and talents necessary. But the facts of the matter are that we have never made the national decisions or marshaled the national resources required for such leadership. We have never specified long-range goals on an urgent time schedule, or managed our resources and our time so as to insure their fulfillment.

It is again time to take urgent, visionary actions that rise to the challenge that we as scientists know is coming. It is time to commit to a Green New Deal.

Dr. Emily Grubert, Ph.D. in Environment and Resources from Stanford University

Dr. Eric Rehm, Senior Research Associate, UMI Takuvik/Arctic Remote Sensing at the Universit Laval

Dr. Dargan Frierson, Associate Professor of Atmospheric Sciences at University of Washington

Dr. Shannon Hateley, Ph.D. in Molecular and Cell Biology from the University of California, Berkeley

Dr. Peter Kalmus, Associate Project Scientist at the UCLA Joint Institute for Regional Earth System Science & Engineering

Matias Kaplan, PhD Candidate in Bioengineering at Stanford University

Isaac Larkin, PhD Candidate in Molecular Biology at Northwestern University

Yan Liu, BSc in Cell and Molecular Biology at San Francisco State University. Co-Founder and CEO, Biocaptivate

David Silverstone, PhD Candidate in Quantum Information Science at Yale University

Dr. Lucky Tran, PhD in Biology from Cambridge University

The rest is here:
Here's the Pro-Bernie Climate Scientist Op-Ed the Washington Post Wouldn't Run - Gizmodo

Inflammation caused by radiation can promote survival of triple-negative breast cancer cells – News-Medical.net

While radiation is successfully used to treat breast cancer by killing cancer cells, inflammation caused as a side-effect of radiation can have a contrary effect by promoting the survival of triple-negative breast cancer cells, according to research published online in the International Journal of Radiation Biology by Jennifer Sims-Mourtada, Ph.D., director of Translational Breast Cancer Research at ChristianaCare's Helen F. Graham Cancer Center & Research Institute.

Accounting for 15-20% of all breast cancers, triple-negative breast cancer is faster growing than other types of breast cancers.

Dr. Sims-Mourtada's latest study, "Radiation induces an inflammatory response that results in STAT3-dependent changes in cellular plasticity and radioresistance of breast cancer stem-like cells," brings scientists closer to understanding the mechanisms behind this aggressive and hard-to-treat cancer. It shows that inflammation caused by radiation can trigger stem-cell-like characteristics in non-stem breast cancer cells.

"This is the good and the bad of radiation," Dr. Sims-Mourtada said. "We know radiation induced inflammation can help the immune system to kill tumor cells -- that's good -- but also it can protect cancer stem cells in some cases, and that's bad."

She added, "What's exciting about these findings is we're learning more and more that the environment the tumor is in - its microenvironment - is very important. Historically, research has focused on the genetic defects in the tumor cells. We're now also looking at the larger microenvironment and its contribution to cancer."

The term triple-negative breast cancer refers to the fact that the cancer cells don't have estrogen or progesterone receptors and also don't make too much of the protein called HER2. The cells test "negative" on all 3 tests. These cancers tend to be more common in women under age 40, who are African-American, Latina or who have a BRCA1 mutation.

My work focuses on cancer stem cells and their origination. They exist in many cancers, but they're particularly elusive in triple-negative breast cancer. Their abnormal growth capacity and survival mechanisms make them resistant to radiation and chemotherapy and help drive tumor growth."

Jennifer Sims-Mourtada, Ph.D., director of Translational Breast Cancer Research at ChristianaCare's Helen F. Graham Cancer Center & Research Institute

She and her team applied radiation to triple-negative breast cancer stem cells and to non-stem cells. In both cases, they found radiation induced an inflammatory response that activated the Il-6/Stat3 pathway, which plays a significant role in the growth and survival of cancer stem cells in triple-negative breast cancers. They also found that inhibiting STAT3 blocks the creation of cancer stem cells. Still unclear is the role IL-6/STAT3 plays in transforming a non-stem cell to a stem-cell.

For women living in Delaware, Dr. Sims-Mourtada's research is especially urgent: The rates of triple-negative breast cancer in the state are the highest nationwide.

At ChristianaCare, we are advancing cancer research to help people in our community today, while we also advance the fight against cancer nationwide. Dr. Sims-Mourtada's research is a dramatic step toward better treatments for triple-negative breast cancer."

Nicholas J. Petrelli, M.D., Bank of America endowed medical director of the Helen F. Graham Cancer Center & Research Institute

To advance her research on inflammation, last year Dr. Sims-Mourtada received a $659,538 grant from the Lisa Dean Moseley Foundation. The three-year grant will enable her and her team at the Cawley Center for Translational Cancer Research to continue investigating the role of cells immediately around a tumor in spurring the growth of triple-negative breast cancer and a possible therapy for this particularly difficult cancer.

"Our next step is to understand the inflammatory response and how we might inhibit it to keep new cancer stem cells from developing," Dr. Sims-Mourtada said.

Dr. Sims-Mourtada's research team previously identified an anti-inflammatory drug, currently used to treat rheumatoid arthritis, that has the potential to target and inhibit the growth of cancer stem cells and triple-negative breast cancer tumors. That research could set the stage for clinical investigation of the drug, alone or in combination with chemotherapy, to improve outcomes for patients with triple-negative breast cancer.

Source:

Journal reference:

Arnold, K.M., et al. (2020) Radiation induces an inflammatory response that results in STAT3-dependent changes in cellular plasticity and radioresistance of breast cancer stem-like cells. International Journal of Radiation Biology. doi.org/10.1080/09553002.2020.1705423.

Read the original here:
Inflammation caused by radiation can promote survival of triple-negative breast cancer cells - News-Medical.net

Researchers discover glial cells that control stress response, extend lifespan in worms – News-Medical.net

While many of us worry about proteins aggregating in our brains as we age and potentially causing Alzheimer's disease or other types of neurodegeneration, we may not realize that some of the same proteins are aggregating in our muscles, setting us up for muscle atrophy in old age.

University of California, Berkeley, scientists have now found brain cells that help clean up these tangles and prolong life -- at least in worms (Caenorhabditis elegans) and possibly mice. This could lead to drugs that improve muscle health or extend a healthy human lifespan.

The research team's most recent discovery, published Jan. 24 in the journal Science, is that a mere four glial cells in the worm's brain control the stress response in cells throughout its body and increase the worm's lifespan by 75%. That was a surprise, since glial cells are often dismissed as mere support cells for the neurons that do the brain's real work, like learning and memory.

This finding follows a 2013 study in which the UC Berkeley group reported that neurons help regulate the stress response in peripheral cells, though in a different way than glial cells, and lengthen a worm's life by about 25%. In mice, boosting neuronal regulation increases lifespan by about 10%.

Together, these results paint a picture of the brain's two-pronged approach to keeping the body's cells healthy. When the brain senses a stressful environment -- invading bacteria or viruses, for example -- a subset of neurons sends electrical signals to peripheral cells to get them mobilized to respond to the stress, such as through breaking up tangles, boosting protein production and mobilizing stored fat. But because electrical signals produce only a short-lived response, the glial cells kick in to send out a long-lasting hormone, so far unidentified, that maintains a long-term, anti-stress response.

"We have been discovering that if we turn on these responses in the brain, they communicate to the periphery to protect the whole organism from the age onset decline that naturally happens. It rewires their metabolism, it also protects against protein aggregation," said Andrew Dillin, UC Berkeley professor of molecular and cell biology and Howard Hughes Medical Institute (HHMI) investigator. As a result of the new study, "We think that glia are going to be more important than neurons."

While the roundworm C. elegans is a long way evolutionarily from humans, the fact that glial cells seem to have a similar effect in mice suggests that the same may be true of humans. If so, it may lead to drugs that combat muscle wasting and obesity and perhaps increase a healthy lifespan.

If you look at humans with sarcopenia or at older mice and humans, they have protein aggregates in their muscle. If we can find this hormone, perhaps it can keep muscle mass higher in older people. There is a huge opportunity here."

Andrew Dillin, UC Berkeley professor of molecular and cell biology and Howard Hughes Medical Institute (HHMI) investigator

In a commentary in the same Jan. 24 issue of Science, two Stanford University scientists, Jason Wayne Miklas and Anne Brunet, echoed that potential. "Understanding how glial cells respond to stress and what neuropeptides they secrete may help identify specific therapeutic interventions to maintain or rebalance these pathways during aging and age-related diseases," they wrote.

Dillin studies the seemingly simultaneous deterioration of cells throughout the body as it ages into death. He has shown in worms and mice that hormones and neurotransmitters released by the brain keep this breakdown in check by activating a stress response in the body's cells and tuning up their metabolism. The response likely originated to fight infection, with the side effect of keeping tissues healthy and extending lifespan. Why our cells stop responding to these signals as we age is the big question.

Over the past decade, he and his colleagues have identified three techniques used by worms to keep their cells healthy and, consequently, longer-lived. Activating the body's heat shock response, for example, protects the cytoplasm of the cell. Stimulating the unfolded protein response protects the cells' energy producing structures, the mitochondria. The unfolded protein response is the cell's way of making sure proteins assume their proper 3D structure, which is crucial for proper functioning inside the cell.

His latest discovery is that glia, as well as neurons, stimulate the unfolded protein response in the endoplasmic reticulum (ER). The ER is the cellular structure that hosts the ribosomes that make proteins -- the ER is estimated to be responsible for the folding and maturation of as many as 13 million proteins per minute.

"A lot of the work we have done has uncovered that certain parts of the brain control the aging of the rest of the animal, in organisms from worms to mice and probably humans," Dillin said.

Two other interventions also increase lifespan in worms: diet restriction, which may call into play other anti-aging mechanisms, and reducing the production of a hormone called insulin-like growth factor (IGF-1).

Dillin's discoveries have already led to new treatments for diseases. He cofounded a company, Mitobridge Inc. (recently acquired by Astellas Pharma Inc.), based on the finding that certain proteins help tune up mitochondria. A drug the company developed is now in phase II clinical trials for treating the damage that occurs when kidneys restart after sudden failure, such as during an operation.

He cofounded another company, Proteostatis Therapeutics, to develop a treatment for cystic fibrosis that is based on activating the unfolded protein response to repair ion channels in people with the disease.

The new discovery about how neurotransmitter and hormones impact the ER could have implications for diseases that involve muscle wasting, such as Huntington's disease and forms of myocytis.

In 2013, Dillin and his colleagues discovered that boosting expression of a protein called xbp-1s in sensory nerve cells in the worm brain boosts the misfolded protein response throughout the worm's body. Shortly afterward, postdoctoral fellow Ashley Frakes decided to see if the glial cells enshrouding these neurons were also involved. When she overexpressed the same protein, xbp-1s, in a subset of these glia (cephalic astrocyte-like sheath glia, or CEPsh), she discovered an even larger effect on peripheral cells, as measured by how they deal with a high-fat diet.

Frakes was able to pinpoint the four CEPsh glia responsible for triggering the ER response, because the C. elegans body is so well studied. There are only 959 cells in the entire worm, 302 of which are nerve cells, and 56 are glial cells.

The CEP neurons and CEPsh glia work differently, but additively, to improve metabolism and clean up protein aggregates as the worms slim down and live twice as long as worms without this protection from a high-fat diet.

"The fact that just a few cells control the entire organism's future is mind-boggling," Dillin said. "Glia work 10 times better than neurons in promoting this response and about twice as good in extending lifespan."

Frakes is currently trying to identify the signaling hormone produced by these glial cells, a first step toward finding a way to activate the response in cells that are declining in function and perhaps to create a drug to tune up human cells and stave off the effects of aging, obesity or other types of stress.

Frakes also found that the worms slimmed down because their fat stores, in the form of lipid droplets, were turned into ER. Another research group in Texas has shown that activating xbp-1s in the neurons of mice also has the effect of reducing fat stores and slimming the mice, protecting them from the effects of a high-fat diet and extending their lifespan.

"When they activate it in the neurons, they see the liver getting rid of fat, redistributing metabolic demands," Dillin said. "I think we would see the same thing in humans, as well."

Source:

Journal reference:

Frakes, A.E., et al. (2020) Four glial cells regulate ER stress resistance and longevity via neuropeptide signaling in C. elegans. Science. doi.org/10.1126/science.aaz6896.

See the rest here:
Researchers discover glial cells that control stress response, extend lifespan in worms - News-Medical.net

Harmful levels of metal linked to DNA damage found in the urine of e-cigarette users – News-Medical.net

Researchers at the University of California, Riverside, have completed a cross-sectional human study that compares biomarkers and metal concentrations in the urine of e-cigarette users, nonsmokers, and cigarette smokers.

They found that the biomarkers, which reflect exposure, effect, and potential harm, are both elevated in e-cigarette users compared to the other groups and linked to metal exposure and oxidative DNA damage.

Our study found e-cigarette users are exposed to increased concentrations of potentially harmful levels of metals -- especially zinc -- that are correlated to elevated oxidative DNA damage."

Prue Talbot, professor of cell biology, University of California, Riverside

Zinc, a dietary nutrient, plays key roles in growth, immune function, and wound healing. Too little of this essential trace element can cause death; too much of it can cause disease. Its deficiency, as well as its excess, cause cellular oxidative stress, which, if unchecked, can lead to diseases such as atherosclerosis, coronary heart disease, pulmonary fibrosis, acute lymphoblastic leukemia, and lung cancer.

Electronic cigarettes consist of a battery, atomizing unit, and refill fluid. Metals in e-cigarette aerosols come mainly from the metal components in the atomizer-- nichrome wire, tin solder joints, brass clamps, insulating sheaths, and wicks -- as well as the e-fluids that the atomizers heat.

The study, which appears in BMJ Open Respiratory Research, marks the first time researchers have examined and quantified urinary biomarkers of effect and potential harm in relation to metals in e-cigarette users.

A biomarker is a quantifiable characteristic of a biological process. Biomarkers allow researchers and physicians to measure a biological or chemical substance that is indicative of a person's physiological state. Previous e-cigarette studies with humans have examined biomarkers of exposure -- for example, nicotine or nicotine metabolites -- but none have studied biomarkers of potential harm or shown how this harm correlates with metal exposure.

The biomarkers studied by the UC Riverside researchers were 8-hydroxydeoxyguanosine (8-OHdG), a biomarker of oxidative DNA damage; 8-isoprostane, an indicator of the oxidative degradation of lipids; and metallothionein, a metal response protein. All three biomarkers were significantly elevated in e-cigarette users compared to the concentrations in cigarette smokers.

"Our findings reaffirm that e-cigarette use is not harm free," said Shane Sakamaki-Ching, a graduate student in the Cell, Molecular and Developmental Biology Graduate Program and the research paper's first author. "Indeed, prolonged use may lead to disease progression."

The researchers advise physicians to exercise caution when recommending e-cigarettes to their patients. Electronic cigarette aerosols contain potentially harmful chemicals, cytotoxic flavor chemicals, metals, ultrafine particles, and reaction products. E-cigarette use has been linked to adverse health effects such as respiratory diseases, increased risk for cardiovascular disease, and impaired wound healing following surgery.

"Pregnant women, especially, should not be encouraged to use e-cigarettes," Talbot said. "Excess of zinc in their bodies can lead to nausea and diarrhea. Given the recent deaths and pulmonary illnesses related to e-cigarette usage, everyone should be made aware of the potential health risks linked to e-cigarette usage."

Source:

Journal reference:

Sakamaki-Ching, S., et al. (2020) Correlation between biomarkers of exposure, effect and potential harm in the urine of electronic cigarette users. BMJ Open Respiratory Research. doi.org/10.1136/bmjresp-2019-000452.

Read more from the original source:
Harmful levels of metal linked to DNA damage found in the urine of e-cigarette users - News-Medical.net

MIT Chemist Investigates How Diseases Are Linked to Flawed Protein Folding – SciTechDaily

When proteins are first made in our cells, they often exist as floppy chains until specialized cellular machinery helps them fold into the right shapes. Only after achieving this correct structure can most proteins perform their biological functions.

Many diseases, including genetic disorders like cystic fibrosis and brittle bone disease, and neurodegenerative diseases like Alzheimers, are linked to defects in this protein folding process. Matt Shoulders, a recently tenured associate professor in the Department of Chemistry, is trying to understand how protein folding happens in human cells and how it goes wrong, in hopes of finding ways to prevent diseases linked to protein misfolding.

In the human cell, there are tens of thousands of proteins. The vast majority of proteins must eventually attain some well-defined three-dimensional structure to carry out their functions, Shoulders says. Protein misfolding and protein aggregation happen a lot, even in healthy cells. My research groups interest is in how cells get proteins folded into a functional conformation, in the right place and at the right time, so they can stay healthy.

In his lab at MIT, Shoulders uses a variety of techniques to study the proteostasis network, which comprises about a thousand components that cooperate to enable cells to maintain proteins in the right conformations.

Proteostasis is exceedingly important. If it breaks down, you get disease, he says. Theres this whole system in cells that helps client proteins get to the shapes they need to get to, and if folding fails the system responds to try and address the problem. If it cant be solved, the network actively works to dispose of misfolded or aggregated client proteins.

Growing up in the Appalachian Mountains, Shoulders was homeschooled by his mother, along with his five siblings. The family lived on a small farm near Blacksburg, Virginia, where his father was an accounting professor at Virginia Tech. Shoulders credits his grandfather, a chemistry professor at Ohio Northern University and Alice Lloyd College, with kindling his interest in chemistry.

My family had a policy that the kids helped clean up the kitchen after dinner. I hated doing it, he recalls. Fortunately for me, there was one exception: If we had company, and if you were in an adult conversation with the company, you could get out of cleaning the kitchen. So I spent many hours, starting at the age of 5 or 6, talking about chemistry with my grandfather after dinner.

Before starting college at nearby Virginia Tech, Shoulders spent a couple of years working as a carpenter.

Matthew Shoulders. Credit: Gretchen Ertl

Thats when I discovered that I really liked building things, he says. When I went to college I was thinking about fields to get into, and I realized chemistry was an opportunity to merge those two things that I had begun to find very exciting building things but also thinking at the molecular level. A big part of what chemists do is make things that have never been made before, by connecting atoms in different ways.

As an undergraduate, Shoulders worked in the lab of chemistry professor Felicia Etzkorn, devising ways to synthesize complex new molecules, including stable peptides that mimic protein functions. In graduate school at the University of Wisconsin, he worked with Professor Ronald Raines, who is now on the faculty at MIT. At Wisconsin, Shoulders began to study protein biophysics, with a focus on the physical and chemical factors that control which structure a given protein adopts and how stable the structure is.

For his graduate studies, Shoulders analyzed how proteins fold while in a solution in a test tube. Once he finished his PhD, he decided to delve into how proteins fold in their natural environment: living cells.

Experiments in test tubes are a great way to get some insight but, ultimately, we want to know how the biological system works, Shoulders says. To that end, he went to the Scripps Research Institute to do a postdoc with professors Jeffery Kelly and Luke Wiseman, who study diseases caused by protein misfolding.

Neurodegenerative diseases like Alzheimers and Parkinsons diseases are perhaps the best known protein misfolding disorders, but there are thousands of others, most of which affect smaller numbers of people. Kelly, Wiseman, and many others, including the late MIT biology professor Susan Lindquist, have shown that protein misfolding is linked to cellular signaling pathways involved in stress responses.

When protein folding goes awry, these signaling pathways recognize it and try to fix the problem. If they succeed, then all is well, but if they fail, that almost always leads to disease, Shoulders says.

Since joining the MIT faculty in 2012, Shoulders and his students have developed a number of chemical and genetic techniques for first perturbing different aspects of the proteostasis network and then observing how protein folding is affected.

In one major effort, Shoulders lab is exploring how cells fold collagen. Collagen, an important component of connective tissue, is the most abundant protein in the human body and, at more than 4,000 amino acids, is also quite large. There are as many as 50 different diseases linked to collagen misfolding, and most have no effective treatments, Shoulders says.

Another major area of interest is the evolution of proteins, especially viral proteins. Shoulders and his group have shown that flu viruses rapid evolution depends in part on their ability to hijack some components of the proteostasis network of the host cells they infect. Without this help, flu viruses cant adapt nearly as rapidly.

In the long term, Shoulders hopes that his research will help to identify possible new ways to treat diseases that arise from aberrant protein folding. In theory, restoring the function of a single protein involved in folding could help with a variety of diseases linked to misfolding.

You might not need one drug for each disease you might be able to develop one drug that treats many different diseases, he says. Its a little speculative right now. We still need to learn much more about the basics of proteostasis network function, but there is a lot of promise.

See the original post:
MIT Chemist Investigates How Diseases Are Linked to Flawed Protein Folding - SciTechDaily

These are 4 medical innovations coming out of Houston institutions – InnovationMap

Houston home to one of the largest medical centers in the world isn't a stranger when it comes to medical innovations and breakthrough research discoveries.

In the latest roundup of research innovations, four Houston institutions are working on innovative and in some cases life-saving research projects.

If the germ,group A streptococcus, continues to grow resistant to antibiotics, it can have a profoundly negative affect on the millions who get the illness annually. Photo via houstonmethodist.org

Researchers at Houston Methodist have discovered some troubling information about the strains of group A streptococcus that cause strep throat and a flesh-eating disease are becoming more resistant to beta-lactams antibiotics like penicillin.

James M. Musser is the lead author of the study and chair of Methodist's Department of Pathology and Genomic Medicine. The study which received funding from grants from the Fondren Foundation, Houston Methodist Hospital and Houston Methodist Research Institute, and the National Institutes of Health appeared in the Jan. 29 issue of the Journal of Clinical Microbiology, according to a news release.

"If this germ becomes truly resistant to these antibiotics, it would have a very serious impact on millions of children around the world," Musser says in the release. "That is a very concerning but plausible notion based on our findings. Development of resistance to beta-lactam antibiotics would have a major public health impact globally."

Musser and his team found 7,025 group A streptococcus strains that have been recorded around the world over the past several decades. Of those strains, 2 percent had gene mutations that raised the alarm for the researchers and, upon investigation, Musser's team came to the conclusion that antibiotic treatments can eventually be less effective or even completely ineffective. This, Musser says, calls for an urgent need to develop a vaccine.

"We could be looking at a worldwide public health infectious disease problem," says Musser in the release. "When strep throat doesn't respond to frontline antibiotics such as penicillin, physicians must start prescribing second-line therapies, which may not be as effective against this organism."

University of Houston Professor Mehmet Orman is looking into cells that are able to persist and cause chronic illnesses. Photo via uh.edu

Mehmet Orman, assistant professor of chemical and biomolecular engineering at the University of Houston, is looking into a specific type of persister cells that have been found to be stubborn and drug-resistant.

The research, which is backed by a $1.9 million grant from the National Institute of Allergy and Infectious Diseases, could answer questions about chronic health issues like airway infections in cystic fibrosis patients, urinary tract infections, and tuberculosis, according to a news release.

"If we know how persister cells are formed, we can target their formation mechanisms to eliminate these dangerous cell types," says Orman in a news release.

Orman is looking into cells' self-digestion, or autophagy, process that is found to stimulate persister formation. Per the release, cells can survive periods of starvation by eating their own elements. Specifically, Orman will analyze self-digestion in E. coli.

"By integrating our expertise in bacterial cell biology with advanced current technologies, we aim to decipher the key components of this pathway to provide a clear and much-needed picture of bacterial self-digestion mechanisms," says Orman in the release.

Some patients are predisposed to kidney injury following surgery, this study found. Photo via bcm.edu

Scientists at Baylor College of Medicine are looking into the lead cause of kidney failure in patients who undergo surgery. Individuals who have heightened levels of suPAR protein soluble urokinase-type plasminogen activator receptor have a greater risk of this post-op complication, according to a news release.

"suPAR is a circulating protein that is released by inflammatory cells in the bone marrow and produced by a number of cell/organs in the body," says Dr. David Sheikh-Hamad, professor of medicine nephrology at Baylor College of Medicine and collaborating author of the study, in the release.

The study, which was published in The New England Journal of Medicine, conducted research on mice that were engineered to hive high suPAR levels in their blood. Compared to the control mice, the suPAR mice had more risk of kidney industry. These mice were given suPAR-blocking antibodies, which then helped reduce kidney injury.

"This protective strategy may be used in humans expressing high suPAR levels prior to contrast exposure, or surgery to decrease the likelihood of developing kidney failure," Sheikh-Hamad says in the release.

Christopher Fagundes of Rice University analyzed the emotions of 99 widows and widowers. Jeff Fitlow/Rice University

A new study done by researchers at Rice University finds that spouses that lose their husband or wife and try to suppress their grief are not doing themselves any favors. The study monitored 99 people who had recently lost a spouse, according to a news release.

"There has been work focused on the link between emotion regulation and health after romantic breakups, which shows that distracting oneself from thoughts of the loss may be helpful," says Christopher Fagundes, an associate professor of psychology and the principal investigator, in a news release. "However, the death of a spouse is a very different experience because neither person initiated the separation or can attempt to repair the relationship."

The study included asking participants to respond to how they felt about certain coping strategies, as well as blood tests to measure cytokines levels an inflammatory marker.

"Bodily inflammation is linked to a host of negative health conditions, including serious cardiovascular issues like stroke and heart attack," Fagundes says in the release.

The research, which was funded by a grant from the National Heart, Lung, and Blood Institute, found that the participants who avoided their emotions suffered more of this bodily inflammation.

"The research also suggests that not all coping strategies are created equal, and that some strategies can backfire and have harmful effects, especially in populations experiencing particularly intense emotions in the face of significant life stressors, such as losing a loved one," adss Richard Lopez, an assistant professor of psychology at Bard College and lead author of the study, in the release.

Read the rest here:
These are 4 medical innovations coming out of Houston institutions - InnovationMap

UAH research could have broad implications for immunotherapy and cancer treatment – News-Medical.net

Research into engineering artificial organs that mimic the functions of human lymph nodes at The University of Alabama in Huntsville (UAH) has garnered one of its professors a $507,777 National Science Foundation (NSF) Faculty Early Career Development Program (CAREER) Award.

The award-winning research by Dr. Kyung-Ho Roh, a UAH assistant professor of chemical and materials engineering, could have broad implications for immunotherapy and cancer treatment. The NSF CAREER Award is the foundation's most prestigious honor for junior faculty members who exemplify the role of teacher-scholars through outstanding research, excellent education and the integration of education and research.

When our body is infected with bacteria or viruses, some special immune cells are 'primed' within the lymph nodes to fight against these 'bugs'. More specifically, there are immune cells named B-cells that are responsible for producing a special set of molecules called antibodies that can recognize and bind to these 'bugs' so that our body can clear them out."

Dr. Kyung-Ho Roh, UAH assistant professor of chemical and materials engineering

The team at his Molecular and Cellular Immunoengineering Laboratory in the UAH Engineering Building is trying to achieve the priming of B-cells in an artificially created engineered system outside of the body.

"Once successful, this research can be useful for various critical biomedical applications," Dr. Roh says. "First, we can use such artificially primed B-cells as living therapeutics that can provide the useful antibodies for an extended period within the patient's body. Second, using the artificial lymph node, we can discover various antibody molecules that can recognize various pathogens or even our own cancers. Third, we can develop safer and cheaper vaccines. Lastly, the artificial system can be used as a critical research tool for studying the physiology of immune-cell related cancers such as lymphomas and leukemias."

Initial development of the hydrogels and microfluidic devices that are the basic foundation of the research project is complete. Now the project is moving forward to use and combine the individual engineering platforms to realize the collective system that can mimic the functions of the lymph nodes.

"For this project, we need a very diverse set of expertise spanning from biomaterials engineering and microfluidics to cellular and molecular biology and immunology," Dr. Roh says.

"For example, in order to mimic the mechanical properties of the physiological soft tissues we are developing novel biomaterials such as polymeric hydrogels," he says. "To culture the B-cells within a controlled chemical environment, we develop and utilize microfluidic devices. For the proper characterizations of the resulting B-cells, various methodologies from cellular and molecular biology are routinely employed."

In the lab, graduate students with diverse backgrounds are collaborating to tackle these challenging interdisciplinary research tasks. Dr. Roh's team is also collaborating with local and international partners such as the HudsonAlpha Institute for Biotechnology and CFD Research Corp.

"In addition to the research activities mentioned above, I will continue to improve my role as an educator. I will develop interdisciplinary educational curricula and continue to nurture the collaborative local networks that can provide a sustainable education and research environment for immunoengineering," Dr. Roh says.

He wants to encourage the participation of the next generation of students from broader socioeconomic groups of North Alabama and to enhance public knowledge of immunoengineering research activities and their applications.

"My primary goal as an educator is to train many undergraduate and graduate students in this highly multidisciplinary topic of immunoengineering to meet the increasing societal demands for such critical skill sets."

Dr. Roh says he received the news of his CAREER Award with a mixture of emotions.

"It was exciting because it assures me that I will be able to continue working on this very significant project and because this award in a way means that the research topics and ideas that we proposed to study are highly appreciated by the leaders in the field," he says. "And the name of the award, CAREER, made me look back and be grateful to everyone who has enabled me to become what I am in my career."

See the article here:
UAH research could have broad implications for immunotherapy and cancer treatment - News-Medical.net